Psychiatry Flashcards
Major depressive disorder
DSM-5 criteria
Depressed mood &/or anhedonia PLUS ≥5 symptoms during the same two week period
-Sleep: Insomnia or hypersomnia
-Interest: Markedly diminished interest/pleasure in activities
-Guilt: Feeling worthless or excessive/inappropriate guilt
-Energy: Fatigue
-Concentration: Decreased concentration or indecisiveness
-Appetite: Significant weight loss/gain, or decreased/increased appetite
-Psychomotor: Psychomotor agitation or retardation
-Suicidal ideation: Recurrent thoughts of death or suicidal ideation
AND significant stress or impairment, substances and other medical & psychiatric conditions ruled out, no history of (hypo)manic episodes
Persistent depressive disorder (dysthymia)
DSM-5 criteria
Depressed mood for most of the day, more days than not, for at least two years PLUS ≥2 symptoms while depressed
- Sleep: Insomnia or hypersomnia
- Energy: Fatigue
- Concentration: Poor concentration or indecisiveness
- Appetite: Poor appetite or overeating
- Low self-esteem
- Feelings of hopelessness
AND substances and other medical & psychiatric conditions ruled out, no history of (hypo)manic episodes
Seasonal affective disorder SAD
MDD with seasonal pattern
Responsive to light therapy
Post-partum depression
MDD beginning during pregnancy or within four weeks following delivery
Distinct from “baby blues,” which is short-lasting (1-2 weeks), does not interfere with daily activities, and resolves without treatment
Melancholic depression
Marked anhedonia and lack of mood reactivity, insomnia (early morning awakening), worse in the mornings
Tx: Tricyclic antidepressants
Atypical depression
Hypersomnia, hyperphagia, leaden paralysis, interpersonal rejection sensitivity
Tx: MAOIs
Depression treatment
SSRIs: Citalopram, escitalopram, sertraline, paroxetine, fluoxetine, fluvoxamine
SNRIs: Venlafaxine, duloxetine
TCAs: Amitriptyline, nortriptyline, doxepin, amoxapine, desipramine, clomipramine, imipramine
MAOIs: Selegiline, phenelzine, tranylcypromine, isocarboxazid
DNRIs: Bupropion
SRI & 5-HT-2A antagonists: Trazodone
Alpha-2 receptor antagonists: Mirtazepine**
Electroconvulsive therapy**
Treat for ≥6 mo before tapering!
Serotonergic side effects
SSRIs: Citalopram, escitalopram, sertraline, paroxetine, fluoxetine, fluvoxamine
SNRIs: Venlafaxine, duloxetine
Transient side effects upon initiation
- Jitteriness, anxiety
- GI disturbance
- Sleep disturbance
Long-term side effects
- Sexual side effects: Dose dependent, does not decrease over time***
- Weight gain
- Bleeding risk: Especially upper GI bleeds
- SIADH: Primarily in the elderly within 2 weeks of starting SSRI
Serotonin syndrome
Vitals: Fever, diaphoresis, autonomic instability
Behavior: Altered mental status, agitation
Exam: Tremors, hyperreflexia, inducible or spontaneous clonus, ocular clonus
Serotonin withdrawal
Flu-like symptoms, agitation, nausea, unsteadiness, dysphoria, electric shock sensation
Risk factors: Medication with shorter half-life, >2 months of treatment, no taper
Treat with fluoxetine
SSRI pearls
SSRIs: Citalopram, escitalopram, sertraline, paroxetine, fluoxetine, fluvoxamine
Citalopram, escitalopram
- Most pure SSRIs, least off-target side effects*
Sertraline
- Most GI side effects
Paroxetine
- Most sedation, weight gain, insomnia, and sexual side effects
- The only SSRI contraindicated in pregnancy
Fluoxetine
- Prominent insomnia, but least weight gain
The SSRIs include fluoxetine, fluvoxamine, sertraline, paroxetine, citalopram, and escitalopram. They inhibit reuptake of serotonin through inhibition of the serotonin transporter, leading to increased availability of serotonin at the postsynaptic membrane. The antidepressant and/or anxiolytic effect of SSRIs may not become apparent for several days to weeks because their mechanism of action involves pre- and postsynaptic receptor changes that are not immediate.
The SSRIs are metabolized by the hepatic cytochrome P450 system and have various drug–drug interactions, with the extent varying with each of the SSRIs. Citalopram and escitalopram have the least potential for drug–drug interactions.
SNRI pearls
SNRIs: Venlafaxine, duloxetine
Venlafaxine
- Mainly an SSRI, no NE effects until 150mg dose
- May increase BP (5%), usually mild
- Prominent discontinuation effects
Duloxetine**
- More robust evidence for neuropathic pain than depression
- FDA approved for diabetic neuropathy, fibromyalgia, and chronic musculoskeletal pain
- Rare incidence of fulminant hepatic failure
Tricyclic antidepressants
TCAs: Amitriptyline (3), nortriptyline (2), doxepin (3), amoxapine (2), desipramine (2), clomipramine (3), imipramine (3)
Mechanism
- Blocks 5-HT & NE re-uptake -> increases synaptic concentration of 5-HT & NE
- Also blocks muscarinic, alpha-1 adrenergic, and histamine-1 receptors: Most prominent in tertiary amines (3), secondary amines (2) have fever side effects, are less sedating, and are safer in overdose
Particularly useful for melancholic depression
The tricyclic antidepressants (TCAs) are among the oldest antidepressants and are still commonly used to treat depression. The TCAs with a tertiary amine side chain such as amitriptyline, doxepin, and imipramine inhibit reuptake of both serotonin and norepinephrine, whereas some such as clomipramine predominantly inhibit reuptake of serotonin. The TCAs do not directly inhibit reuptake of dopamine, though they may indirectly facilitate the effects of dopamine.
Tricyclic antidepressant side effects
TCAs: Amitriptyline, nortriptyline, doxepin, amoxapine, desipramine, clomipramine, imipramine
Anti-cholinergic: Blind as a bat (blurry vision), dry as a bone (dry mouth), full as a flask (urinary retention, constipation), mad as a hatter (confusion); slowed cardiac conduction (AV block, arrhythmias); lowers seizure threshold***
Anti-alpha-1 adrenergic: Orthostatic hypotension
Anti-histamine: Sedation, weight gain*
Serotonergic: Sexual dysfunction
Overdose
Can be lethal!
Cardiotoxicity: Slowed cardiac conduction (AV block, arrhythmias)
Neurotoxicity: Agitation, delirium, coma
Withdrawal
Irritability, dizziness, nausea, diaphoresis, insomnia
All TCAs have some activity at muscarinic, histaminergic, and α1-adrenergic receptors, though to varying degrees. Because of these effects at noncatecholaminergic receptors, they are used for various disorders not limited to depression and anxiety, including urinary retention and neuropathic pain.
MAOIs
MAOIs: Selegiline, phenelzine, tranylcypromine, isocarboxazid
Mechanism
Monoamine oxidase metabolizes monoamines (5-HT, NE, DA)
MAOIs irreversibly inhibit MAO-A & MAO-B: increases 5-HT, NE, DA
Also blocks alpha-1 adrenergic & histamine-1 receptors
Particularly useful for atypical depression
Side-effects
Anti-alpha-1 adrenergic: Orthostatic hypotension
Anti-histamine: Sedation, weight gain
Serotonergic: Sexual dysfunction, insomnia, myoclonus
Hepatotoxicity (rare)
Tyramine-induced hypertensive crisis: Tyramine is normally broken down in the GI tract by MAO-A. On MAOIs, it isn’t broken down, so more is absorbed into the bloodstream. Activates adrenergic pathways, precipitating catastrophic rise in BP. Must avoid high tyramine foods (wine, aged cheese, fava beans, liver).
Phenelzine and isocarboxazid are nonselective monoamine oxidase inhibitors (MAOIs) and are among the oldest antidepressants, rarely used in clinical practice today due to their side effect profile. Because nonselective MAOIs block metabolism of tyramine, found in certain foods such as cheese and wine, a lethal reaction resulting from hyperadrenergic state can occur with use of MAOIs, particularly when taken with other agents that increase serotonin.
Bupropion**
DNRI
Blocks NE & DA reuptake
Avoids anti-cholinergic, anti-alpha-1 adrenergic (orthostatic hypotension), anti-histaminergic (weight gain) and serotonergic (sexual dysfunction) side effects**
Decreases seizure threshold, contraindicated in eating disorders
Also used for smoking cessation**
It inhibits reuptake of norepinephrine and dopamine and increases presynaptic release of these neurotransmitters, without direct effects on the serotonin system.
Different from busprinone: Buspirone is an anxiolytic agent without sedative–hypnotic activity. Its mechanism of action involves partial agonism at serotonergic (5-HT1A) receptors. It also has some activity at dopaminergic D2 receptors.
Trazodone
SRI & 5-HT2A receptor antagonists
Mainly blocks reuptake of serotonin
Anti-alpha-1 adrenergic: Orthostatic hypotension, priapism
Anti-histaminergic: Sedation (helpful for insomnia)
Mirtazepine**
Alpha-2 receptor antagonists
Stimulates alpha-1 receptors, blocks alpha-2 receptors, and blocks 5-HT-2A receptors, overall increasing 5-HT & NE release
Anti-histaminergic: Sedation (helpful for insomnia), weight gain (helpful for stimulating appetite)**
Mirtazapine has complex pharmacology; it acts as an antagonist at presynaptic α2-receptors, increasing release of norepinephrine and serotonin, and also acts as an antagonist at 5-HT2 and 5-HT3 receptors. Its potent antagonism at histamine receptors accounts for its sedating effects.
Mania
DSM-5 criteria
Abnormally elevated, expansive, or irritable mood & persistently goal-directed behavior or energy, lasting at least one week PLUS ≥3-4 of the following symptoms
- Distractibility
- Impulsivity
- Grandiosity
- Flight of ideas or racing thoughts
- Activity: Increase in goal-directed activity or psychomotor agitation
- Sleep: Decreased need for sleep yet feels rested
- Talkative: More talkative than usual or pressure to keep talking
AND marked impairment or psychotic features, substances and other medical conditions ruled out
Bipolar disorder I vs II
Treatment of bipolar disorder
Mood stabilizer - S/Es and pregnancy
Lithium side-effects/toxicity
S/E’s
Most common: Polyuria & thirst, weight gain, tremor*
Neuro: Decreased cognition, tremor, incoordination
Cardiac: Decreases sinoatrial node conduction (avoid in sick sinus syndrome)
Renal: Polyuria (antagonistic effect on ADH)
GI: Nausea, vomiting, anorexia, dyspepsia, diarrhea
Endo: Weight gain, hypothyroidism
Skin: Hair loss, acne, psoriasis
Heme: Benign leukocytosis
Toxicity
Narrow therapeutic index
Not metabolized; excreted in urine
Levels can become toxic due to:
- Renal insufficiency
- Dehydration (fever, excessive sweating, GI illness)**
- Decreased sodium intake (lithium reabsorption in proximal tubule)**
- Drug-drug interactions: NSAIDs, thiazide diuretics, ACE inhibitors
Acute toxicity
- Nausea, vomiting, diarrhea -> dehydration & compromised renal function
- Confusion, tremor, seizures (including nonconvulsive status)
- Arrhythmia (rare)
Causes of secondary mania
Neurological
- Stroke (right prefrontal),* subdural hematoma, tumor, multiple sclerosis, Huntington’s disease, dementia, seizures
Medical
- Hypothyroidism, hyperthyroidism, carcinoid syndrome, sleep apnea, delirium
Substance-induced
- Dopamine agonists, anabolic and corticosteroids, sympathomimetics (PCP, amphetamines, pseudoephedrine)